Carlos Angeles

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

September 9, 2019 Carlos Angeles

Biosimilars Forum’s Public Letter In Response to Anti-Biosimilars Op-Ed

August 22, 2019 Carlos Angeles

New Analysis Encourages Employer Engagement to Help Realize Significant Savings Potential of Biosimilars

July 30, 2019 Carlos Angeles

Forum Statement in Response to Senate Finance Committee Advancing its Drug Pricing Package

July 25, 2019 Carlos Angeles

Forum Statement on Senate Finance Provision and New Amendment That Could Save Taxpayers and Seniors Billions

July 23, 2019 Carlos Angeles

Senate Finance Provision Increasing ASP for Biosimilars Could Unlock Billions in Savings for Patients and Taxpayers

July 11, 2019 Carlos Angeles

New Analysis Confirms Increased Use of Biosimilars Can Save U.S. Up to $71 Billion Over a Decade

June 20, 2019 Carlos Angeles

Health Experts Agree Increasing Biosimilar Use Can Help Reduce Rising Drug Costs for Patients

May 29, 2019 Carlos Angeles

Biosimilars Forum Announces Support for Policies that Would Save Taxpayers and Seniors Billions

May 23, 2019 Carlos Angeles

The Biosimilars Forum Commends Senate HELP Committee’s Effort to Educate Patients and Providers on Biosimilars

March 19, 2019 Carlos Angeles

Significant Healthcare Savings Possible if U.S. Cultivates a Robust Biosimilars Market